YOUNG JAMES EMMETT (Chief Financial Officer) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0001415889-25-004688
Officer· Chief Financial Officer
Since Jan 2025
+14.76K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
14.76K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.76K
Price / share
—
Trade value
—
% of position
67.9%
2/18/2025
21.73K→36.49K
Total
Net shares
+14.76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2025 | A · Award | +14.76K | — | — | 67.9% | 21.73K | 36.49K |
| Total | +14.76K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned30K
Total
30K indirect30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 30K | Indirect |
| Total | 30K | 30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported